JVLazarus Profile Banner
Jeffrey V. Lazarus Profile
Jeffrey V. Lazarus

@JVLazarus

Followers
9K
Following
24K
Media
3K
Statuses
22K

Committed to people-centred health systems. Director #SLDthinktank. Professor @CUNYSPH @ISGLOBALorg @JVLazarus.bsky.social Loraxian #LiverTwitter

CPH • BCN • NYC • En el Camino
Joined November 2012
Don't wanna be here? Send us removal request.
@JVLazarus
Jeffrey V. Lazarus
3 years
Today is the day! The @Nature #COVIDconsensus paper is now live at All of our recommendations are 100% within human control and we need your help to spread the message to end #COVID19 as a #publichealth threat! #CovidTwitter
Tweet media one
102
1K
3K
@JVLazarus
Jeffrey V. Lazarus
10 hours
RT @scottisaacsmd: Excellent editorial in the @NEJM about the need to redefine clinical endpoints in MASH cirrhosis trials. With up to 25%….
0
19
0
@JVLazarus
Jeffrey V. Lazarus
2 days
JUST OUT: "The Rising Global Burden of MASLD and Other Metabolic Diseases (2000–2021)".In 2021, MASLD had a prevalence of 1.27 billion people while T2DM had a prevalence of 0.51 billion people worldwide. #LiverTwitter @PojsakornDan.
0
13
38
@JVLazarus
Jeffrey V. Lazarus
6 days
The Global Metabolic Health Roundtable series recently held 3 regional meetings to unite leaders in Asia, Latin America and the MENA regions in supporting the call to include chronic liver disease in the UNGA HLM Declaration, aligned w the #SLDthinktank.
0
1
4
@JVLazarus
Jeffrey V. Lazarus
7 days
From steatotic liver disease to #Catanconnect today with 40 countries playing. We crushed it including longest road in Denmark and the intermission prize. So fun to disconnect and take over the island 😂
Tweet media one
Tweet media two
Tweet media three
Tweet media four
0
0
5
@JVLazarus
Jeffrey V. Lazarus
8 days
An important correspondence and here is our response We need to continue to grow the MASLD community of practice. #LiverTwitter.
@NatRevGastroHep
Nature Reviews Gastroenterology & Hepatology
8 days
New online! Pregnancy and liver health: delivering new collaborations to advance the MASLD and MASH field
1
1
11
@JVLazarus
Jeffrey V. Lazarus
8 days
RT @NatRevGastroHep: New online! Reply to ‘Pregnancy and liver health: delivering new collaborations to advance the MASLD and MASH field’ h….
0
6
0
@JVLazarus
Jeffrey V. Lazarus
9 days
RT @AEEHLiver: 🔝De Barcelona al mundo: un 'think tank' global sobre enfermedades hepáticas aparece en los titulares y entra en el registro….
0
1
0
@JVLazarus
Jeffrey V. Lazarus
10 days
From Barcelona to the World: Global Think‑tank on Liver Disease Makes Headlines and Enters the Scientific Record.#SLDthinktank #LiverTwitter
Tweet media one
2
4
20
@JVLazarus
Jeffrey V. Lazarus
12 days
RT @scottisaacsmd: Proud to see the outcomes of the Global Think-tank on Steatotic Liver Disease 2025 meeting in Barcelona featured in @The….
0
19
0
@JVLazarus
Jeffrey V. Lazarus
14 days
Honoured to second author the most cited article in @HEP_Journal. Led by the great @marurinella and seniored by Dr Phil Newsome: #LiverTwitter.
@AASLDtweets
AASLD
15 days
The 2024 Impact Factors are in, and we have good news! We're proud to share that the Impact Factor for @HEP_Journal—the leading scientific journal in #liverdisease—increased to 15.8. Check out the top 10 cited articles here: .#Hepatology #AASLD
Tweet media one
1
1
13
@JVLazarus
Jeffrey V. Lazarus
14 days
Important for #ADASciSessions - happening now in Chicago.
@LancetGastroHep
The Lancet Gastroenterology & Hepatology
8 months
Individuals with type 2 diabetes are at higher risk for clinically relevant liver disease. Could including liver health checks in annual diabetes reviews allow early interventions to prevent end-stage liver disease?. #LiverTwitter #WorldDiabetesDay.
0
0
1
@JVLazarus
Jeffrey V. Lazarus
19 days
RT @scottisaacsmd: Honored to see the @TheAACE MASLD algorithm featured in the expert consensus statement on #MASLD from the Indian diabeto….
0
40
0
@JVLazarus
Jeffrey V. Lazarus
21 days
RT @ArunJSanyalVCU: ICYMI: I was honored to participate in @EASLedu's recent online presentation, Steatotic Liver Disease Unpacked: Targeti….
0
2
0
@JVLazarus
Jeffrey V. Lazarus
23 days
RT @DrJayyy__: We renamed a disease—not for science, but for people. 🩺. Proud to co-author the People-First Liver Charter alongside greats….
0
4
0
@JVLazarus
Jeffrey V. Lazarus
26 days
Yup, before our clinical trial meeting in Liverpool, we were "those" tourists. #PennyLane "is in my ears and in my eyes".
Tweet media one
Tweet media two
Tweet media three
Tweet media four
0
1
2
@JVLazarus
Jeffrey V. Lazarus
26 days
After the Global Think-tank on Steatotic Liver, I paddlesurfed in BCN out to my yellow submarine LOL. where among other things we launched the People-First Liver Charter:.#SLDthinktank #LiverTwitter
Tweet media one
Tweet media two
Tweet media three
1
1
5
@JVLazarus
Jeffrey V. Lazarus
27 days
RT @DrJavierCrespo: MASH with F2+ fibrosis is silently killing millions. This paper calls for DOUBLING diagnosis rates by 2027—using AI, NI….
0
13
0
@JVLazarus
Jeffrey V. Lazarus
28 days
Buenos dias #Barcelona. ! Time to paddle-surf. 6.21am
Tweet media one
Tweet media two
1
0
16
@JVLazarus
Jeffrey V. Lazarus
28 days
RT @Daniel_Veldaco: Yesterday, I joined a roundtable at the #GlobalThinkTank on Steatotic Liver Disease to discuss how cities can drive hea….
0
2
0
@JVLazarus
Jeffrey V. Lazarus
30 days
RT @scottisaacsmd: Using people-first language helps to reduce stigma, enhance care experiences, boost treatment engagement, and promote be….
0
11
0